Tilray Brands, Inc. (TLRY.TO)
CAD 0.62
(-6.06%)
CAD 0.62
(-6.06%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 252.08 Million USD | 25.7% |
| 2022 | 200.55 Million USD | -18.32% |
| 2021 | 245.52 Million USD | -4.25% |
| 2020 | 256.42 Million USD | 34.57% |
| 2019 | 190.56 Million USD | 181.69% |
| 2018 | 67.64 Million USD | 293.82% |
| 2017 | 17.17 Million USD | 495.41% |
| 2016 | 2.88 Million USD | 80.14% |
| 2015 | 1.6 Million USD | 15.44% |
| 2014 | 1.38 Million USD | 0.0% |
| 2013 | - CAD | 100.0% |
| 2012 | -0.06 USD | 61.73% |
| 2011 | -0.15 USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 264.29 Million USD | 15.72% |
| 2023 FY | 252.08 Million USD | 25.7% |
| 2023 Q4 | 252.08 Million USD | 3.26% |
| 2023 Q3 | 244.13 Million USD | -3.39% |
| 2023 Q2 | 252.7 Million USD | 8.89% |
| 2023 Q1 | 232.07 Million USD | 15.72% |
| 2022 Q4 | 200.55 Million USD | -1.11% |
| 2022 FY | 200.55 Million USD | -18.32% |
| 2022 Q1 | 244.65 Million USD | -0.36% |
| 2022 Q2 | 240.94 Million USD | -1.52% |
| 2022 Q3 | 202.8 Million USD | -15.83% |
| 2021 Q2 | 233.02 Million USD | -7.35% |
| 2021 Q1 | 251.5 Million USD | -1.92% |
| 2021 Q4 | 245.52 Million USD | -10.16% |
| 2021 Q3 | 273.29 Million USD | 17.28% |
| 2021 FY | 245.52 Million USD | -4.25% |
| 2020 Q3 | 267.5 Million USD | -0.89% |
| 2020 Q2 | 269.89 Million USD | 2.73% |
| 2020 Q1 | 262.71 Million USD | 37.86% |
| 2020 FY | 256.42 Million USD | 34.57% |
| 2020 Q4 | 256.42 Million USD | -4.14% |
| 2019 FY | 190.56 Million USD | 181.69% |
| 2019 Q1 | 84.53 Million USD | 24.96% |
| 2019 Q3 | 168.56 Million USD | 47.19% |
| 2019 Q2 | 114.52 Million USD | 35.48% |
| 2019 Q4 | 190.56 Million USD | 13.05% |
| 2018 FY | 67.64 Million USD | 293.82% |
| 2018 Q4 | 67.64 Million USD | 3.14% |
| 2018 Q3 | 65.58 Million USD | 115.87% |
| 2018 Q2 | 30.38 Million USD | 13.55% |
| 2018 Q1 | 26.75 Million USD | 55.77% |
| 2017 Q3 | 9.2 Million USD | 36.09% |
| 2017 Q4 | 17.17 Million USD | 86.58% |
| 2017 FY | 17.17 Million USD | 495.41% |
| 2017 Q1 | 4.72 Million USD | 63.89% |
| 2017 Q2 | 6.76 Million USD | 43.08% |
| 2016 FY | 2.88 Million USD | 80.14% |
| 2016 Q4 | 2.88 Million USD | 43.35% |
| 2016 Q3 | 2.01 Million USD | -5.96% |
| 2016 Q1 | 2.08 Million USD | 30.2% |
| 2016 Q2 | 2.14 Million USD | 2.64% |
| 2015 FY | 1.6 Million USD | 15.44% |
| 2015 Q4 | 1.6 Million USD | 18.67% |
| 2015 Q3 | 1.34 Million USD | -10.75% |
| 2015 Q2 | 1.51 Million USD | -2.65% |
| 2015 Q1 | 1.55 Million USD | 11.96% |
| 2014 FY | 1.38 Million USD | 0.0% |
| 2014 Q4 | 1.38 Million USD | 92.35% |
| 2014 Q3 | 721.28 Thousand USD | 106.89% |
| 2014 Q2 | 348.63 Thousand USD | 2939.57% |
| 2014 Q1 | 11.47 Thousand USD | 10357787.9% |
| 2013 Q2 | - USD | 100.0% |
| 2013 Q1 | -0.06 USD | 88.73% |
| 2013 FY | - CAD | 100.0% |
| 2013 Q4 | -0.11 USD | -380496306800.0% |
| 2013 Q3 | - USD | 100.0% |
| 2012 FY | -0.06 USD | 61.73% |
| 2012 Q1 | -0.15 USD | -15069485.26% |
| 2012 Q4 | -0.51 USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q2 | - USD | 100.0% |
| 2011 FY | -0.15 USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q4 | - USD | -100.0% |
| 2011 Q3 | 0.32 USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Aurora Cannabis Inc. | 186.37 Million CAD | -35.257% |
| Avicanna Inc. | 4.54 Million CAD | -5447.399% |
| Avant Brands Inc. | 28.93 Million CAD | -771.158% |
| Cardiol Therapeutics Inc. | -279.87 Thousand CAD | 90172.247% |
| Crescita Therapeutics Inc. | 6.12 Million CAD | -4015.706% |
| Knight Therapeutics Inc. | 91.83 Million CAD | -174.503% |
| MediPharm Labs Corp. | 9.89 Million CAD | -2446.591% |
| OrganiGram Holdings Inc. | 80.95 Million CAD | -211.399% |
| Canopy Growth Corporation | 77.29 Million CAD | -226.149% |
| Willow Biosciences Inc. | 221 Thousand CAD | -113966.516% |
| Auxly Cannabis Group Inc. | 31.42 Million CAD | -702.084% |